In order to determine whether ibuprofen decreases the expression of these novel candidate genes to further diminish cancer cell stemness, we investigated the expression of novel candidate genes and stemness markers (SOX2 and OCT4) in A549 lung cancer cells, MDA-MB-231 breast cancer cells and HepG2 liver cancer cells using western blot. The gene discussed is SOX2; the disease is lung carcinoma.